Skip to main content

Molluscum Contagiosum News

FDA Approves Zelsuvmi (berdazimer topical gel) for the Treatment of Molluscum Contagiosum

SAN DIEGO--(BUSINESS WIRE) January 5, 2024 – Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that the U.S. Food and Drug Administration (FDA) has approved Zelsuvmi™ (berdazimer t...

FDA Approves Ycanth (cantharidin) Topical Solution for the Treatment of Molluscum Contagiosum

WEST CHESTER, PA –Jul 21, 2023 (GLOBE NEWSWIRE) – Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Dermatological Disorders